Docetaxel Anhydrous Injection, Solution
Product Images NDC 71288-144

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Docetaxel Anhydrous (NDC 71288-144). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Meitheal Pharmaceuticals Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Docetaxel Structural Formula (Doc09 0000 01)

Chemical structure of Docetaxel anhydrous, the active ingredient in the injection solution by Meitheal Pharmaceuticals Inc.*

FDA Label Image

Figure 1 (Doc09 0000 02)

A survival curve chart depicting Disease-Free Survival (DFS) probability over time in months. It compares two groups labeled TAC and FAC, showing DFS probability on the vertical axis and Disease-Free Survival Time on the horizontal axis, with TAC maintaining a higher DFS probability over the observed period.*

FDA Label Image

Figure 2 (Doc09 0000 03)

A survival probability curve chart comparing two treatment groups labeled TAC and FAC over a timeline of up to 66 months. The y-axis represents survival probability in percentage, and the x-axis shows survival time in months, illustrating differences in survival trends between the two groups.*

FDA Label Image

Figure 3 (Doc09 0000 04)

A Kaplan-Meier survival curve chart depicting cumulative probability against survival time in months. Two curves labeled 'T75' and 'BSC' compare overall survival, with the T75 group showing higher survival probability than BSC. The chart includes a log-rank p-value of 0.010, indicating statistical analysis of survival difference.*

FDA Label Image

Figure 4 (Doc09 0000 05)

A survival curve chart showing cumulative probability versus survival time in months. Two groups, labeled T75 and V/I, are compared with a log-rank p-value of 0.13 indicating overall survival. The chart spans survival times from 0 to 21 months with cumulative probability ranging from 0 to 1.*

FDA Label Image

Figure 5 (Doc09 0000 06)

A Kaplan-Meier survival probability curve chart showing survival time in months on the x-axis and survival probability on the y-axis. It compares two groups labeled T75 q3w and M q3w, illustrating differences in survival probability over a 30-month period.*

FDA Label Image

Figure 6 (Doc09 0000 07)

A Kaplan-Meier survival curve graph comparing two groups labeled TCF and CF. The y-axis represents probability percentage from 0 to 100%, and the x-axis shows time in months, ranging from 0 to 24. The curves show a decreasing survival probability over time for both groups, with TCF maintaining a higher probability than CF throughout the period.*

FDA Label Image

Figure 7 (Doc09 0000 08)

A survival probability curve chart comparing two groups labeled TCF and CF over 36 months. The y-axis represents survival probability as a percentage, decreasing from 100% to 0%, while the x-axis shows survival time in months from 0 to 36. The chart displays two declining survival curves with TCF showing a generally higher survival probability than CF over time.*

FDA Label Image

Figure 8 (Doc09 0000 09)

A Kaplan-Meier curve chart depicting Progression-Free Survival (PFS) probability over time in months. Two survival curves are shown: one solid line labeled TPF and one dashed line labeled PF, with PFS probability decreasing as time progresses from 0 to 42 months.*

FDA Label Image

Figure 9 (Doc09 0000 10)

A survival probability chart showing two curves labeled TPF and PF. The x-axis represents survival time in months up to 72, and the y-axis shows survival probability percentage from 0 to 100. The graph depicts comparative survival outcomes over time for the two groups.*

FDA Label Image

Figure 10 (Doc09 0000 11)

A Kaplan-Meier survival curve chart comparing survival probability (%) over time in months for patients treated with TPF (solid line, n=255) versus PF (dashed line, n=246). The graph depicts higher survival probabilities over time for the TPF group. Below the graph is a table showing the number of patients at risk at various time points up to 72 months.*

FDA Label Image

Principal Display Panel – Docetaxel Injection, Usp 8 mL Vial Label (Doc09 0000 14)

Label for Docetaxel Injection, USP 80 mg per 8 mL (10 mg per mL) intravenous injection solution. The multi-dose vial formulation is manufactured by Meitheal Pharmaceuticals Inc. The label includes warnings such as cautioning it as a cytotoxic agent, directions for adding to infusion solution, storage instructions, and notes that the vial is sterile and preservative-free.*

FDA Label Image

Principal Display Panel – Docetaxel Injection, Usp 8 mL Carton (Doc09 0000 15)

Packaging label for Docetaxel Injection, USP 80 mg per 8 mL (10 mg per mL) intravenous injection solution. Multi-dose vial, ready to add to infusion solution, labeled as a cytotoxic agent. Manufactured for Meitheal Pharmaceuticals Inc., Chicago, IL. Warning to keep out of reach of children and storage instructions included. NDC 71288-144-08.*

FDA Label Image

Principal Display Panel – Docetaxel Injection, Usp 16 mL Vial Label (Doc09 0000 16)

Label for Docetaxel Injection, USP 160 mg per 16 mL (10 mg per mL) by Meitheal Pharmaceuticals Inc. This is an intravenous injection solution in a 16 mL multi-dose vial. The label notes the product is a cytotoxic agent, sterile, preservative-free, and comes in a nonpyrogenic container not made with natural rubber latex. It includes usage, storage, and dosage instructions along with the NDC 71288-144-16.*

FDA Label Image

Principal Display Panel – Docetaxel Injection, Usp 16 mL Carton (Doc09 0000 17)

Packaging label for Docetaxel Injection, USP 160 mg per 16 mL (10 mg per mL) intravenous injection solution by Meitheal Pharmaceuticals Inc. The label states it is a multi-dose vial, ready to add to infusion solution, and includes warnings about cytotoxicity and storage instructions. The box includes detailed drug content and handling information alongside a barcode and manufacturer details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.